GHRP-6 (Cardiac) refers to the cardioprotective applications of Growth Hormone Releasing Peptide-6 beyond its primary use as a growth hormone secretagogue. While GHRP-6 is known for stimulating GH release, research has revealed significant cardioprotective effects independent of growth hormone. The peptide has been shown to protect cardiac tissue from ischemia-reperfusion injury, reduce infarct size following myocardial events, and promote cardiac tissue repair. These effects are mediated through activation of specific cardiac receptors distinct from the pituitary GHS-R1a receptor, making GHRP-6 of particular interest in cardiovascular research.
| Research Status | Preclinical |
|---|---|
| Half-Life | 15-30 minutes |
| Administration | Subcutaneous injection |
| Typical Dosage | 100-300 mcg |
| Molecular Weight | 873.0 Da |
| Molecular Formula | C46H56N12O6 |
CD36 receptor activation in cardiac tissue, independent of GH release.
All information is presented for Research Use Only (RUO). Not medical advice.